KUALA LUMPUR (March 12): Biov Global Bhd, a regenerative medicine company, has emerged as a substantial shareholder in Malaysian Genomics Resource Centre Bhd (KL:MGRC).

Biov Global crossed the 5% disclosure threshold after it acquired an additional 4.317% stake, or 6.52 million shares, in the ACE Market-listed genomics and biopharmaceutical firm via a direct business transaction on Thursday, according to a bourse filing.

Its total stake in MGRC stands at 5.165% after the acquisition. The value at which the shares were transacted was not disclosed in the filing.

According to a Companies Commission Malaysia filing, Biov Global is 27.12%-owned by Lim Kean Lam. Other shareholders include GM Biovalley Sdn Bhd with 16.95%, Dr Wong Jeh Shyan (8.18%), Shing Yiu Fai (7.2%), Barath Malla Naidu (4.82%), Affluxury Bhd (4.23%), Versatile Maxim Bhd (3.39%), Tan Sheau Huey (3.39%) and VI Wellness Ltd (2.8%). 

MGRC’s other substantial shareholders comprise Proven Venture Capital with 14.84%, Pixelvest Sdn Bhd PLT with 6.33% and executive chairman and managing director Leong Yien Hung with 5.59%.

MGRC has been loss-making for the past four financial years. For its latest financial year ended Dec 31, 2025, the company posted a net loss of RM2.38 million on revenue of RM8.02 million.

Shares in MGRC ended unchanged at 20 sen on Thursday, valuing the company at RM30.19 million.